Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the Pancreas

Edgar Ben-Josef, Asha George, William F. Regine, Ross Abrams, Meredith Morgan, Dafydd Thomas, Paul L. Schaefer, Thomas A. DiPetrillo, Mitchel Fromm, William Small, Samir Narayan, Kathryn Winter, Kent A. Griffith, Chandan Guha, Terence M. Williams

Research output: Contribution to journalArticle

Abstract

Purpose: GSK3β is a protein kinase that can suppress a number of key oncoproteins. We have previously shown in preclinical models of pancreatic ductal adenocarcinoma (PDAC) that inhibition of GSK3β causes stabilization and nuclear translocation of b-catenin, poor differentiation, proliferation, and resistance to radiation. The objective of this study was to determine its utility as a biomarker of clinical outcomes. Experimental Design: Automated Quantitative Immunofluorescence Analysis (AQUA) of GSK3β was performed on a tissue microarray with samples from 163 patients treated on RTOG 9704. On the basis of findings in an exploratory cohort, GSK3β was analyzed as a categorical variable using its upper quartile (

Original languageEnglish (US)
Pages (from-to)5612-5618
Number of pages7
JournalClinical Cancer Research
Volume21
Issue number24
DOIs
StatePublished - Dec 15 2015

Fingerprint

Catenins
Oncogene Proteins
Protein Kinases
Fluorescent Antibody Technique
Pancreas
Adenocarcinoma
Research Design
Biomarkers
Radiation
Survival
Glycogen Synthase Kinase 3 beta

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Ben-Josef, E., George, A., Regine, W. F., Abrams, R., Morgan, M., Thomas, D., ... Williams, T. M. (2015). Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the Pancreas. Clinical Cancer Research, 21(24), 5612-5618. https://doi.org/10.1158/1078-0432.CCR-15-0789

Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the Pancreas. / Ben-Josef, Edgar; George, Asha; Regine, William F.; Abrams, Ross; Morgan, Meredith; Thomas, Dafydd; Schaefer, Paul L.; DiPetrillo, Thomas A.; Fromm, Mitchel; Small, William; Narayan, Samir; Winter, Kathryn; Griffith, Kent A.; Guha, Chandan; Williams, Terence M.

In: Clinical Cancer Research, Vol. 21, No. 24, 15.12.2015, p. 5612-5618.

Research output: Contribution to journalArticle

Ben-Josef, E, George, A, Regine, WF, Abrams, R, Morgan, M, Thomas, D, Schaefer, PL, DiPetrillo, TA, Fromm, M, Small, W, Narayan, S, Winter, K, Griffith, KA, Guha, C & Williams, TM 2015, 'Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the Pancreas', Clinical Cancer Research, vol. 21, no. 24, pp. 5612-5618. https://doi.org/10.1158/1078-0432.CCR-15-0789
Ben-Josef, Edgar ; George, Asha ; Regine, William F. ; Abrams, Ross ; Morgan, Meredith ; Thomas, Dafydd ; Schaefer, Paul L. ; DiPetrillo, Thomas A. ; Fromm, Mitchel ; Small, William ; Narayan, Samir ; Winter, Kathryn ; Griffith, Kent A. ; Guha, Chandan ; Williams, Terence M. / Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the Pancreas. In: Clinical Cancer Research. 2015 ; Vol. 21, No. 24. pp. 5612-5618.
@article{686a7501fe7d448f85b9b9ced0ac163e,
title = "Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the Pancreas",
abstract = "Purpose: GSK3β is a protein kinase that can suppress a number of key oncoproteins. We have previously shown in preclinical models of pancreatic ductal adenocarcinoma (PDAC) that inhibition of GSK3β causes stabilization and nuclear translocation of b-catenin, poor differentiation, proliferation, and resistance to radiation. The objective of this study was to determine its utility as a biomarker of clinical outcomes. Experimental Design: Automated Quantitative Immunofluorescence Analysis (AQUA) of GSK3β was performed on a tissue microarray with samples from 163 patients treated on RTOG 9704. On the basis of findings in an exploratory cohort, GSK3β was analyzed as a categorical variable using its upper quartile (",
author = "Edgar Ben-Josef and Asha George and Regine, {William F.} and Ross Abrams and Meredith Morgan and Dafydd Thomas and Schaefer, {Paul L.} and DiPetrillo, {Thomas A.} and Mitchel Fromm and William Small and Samir Narayan and Kathryn Winter and Griffith, {Kent A.} and Chandan Guha and Williams, {Terence M.}",
year = "2015",
month = "12",
day = "15",
doi = "10.1158/1078-0432.CCR-15-0789",
language = "English (US)",
volume = "21",
pages = "5612--5618",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "24",

}

TY - JOUR

T1 - Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the Pancreas

AU - Ben-Josef, Edgar

AU - George, Asha

AU - Regine, William F.

AU - Abrams, Ross

AU - Morgan, Meredith

AU - Thomas, Dafydd

AU - Schaefer, Paul L.

AU - DiPetrillo, Thomas A.

AU - Fromm, Mitchel

AU - Small, William

AU - Narayan, Samir

AU - Winter, Kathryn

AU - Griffith, Kent A.

AU - Guha, Chandan

AU - Williams, Terence M.

PY - 2015/12/15

Y1 - 2015/12/15

N2 - Purpose: GSK3β is a protein kinase that can suppress a number of key oncoproteins. We have previously shown in preclinical models of pancreatic ductal adenocarcinoma (PDAC) that inhibition of GSK3β causes stabilization and nuclear translocation of b-catenin, poor differentiation, proliferation, and resistance to radiation. The objective of this study was to determine its utility as a biomarker of clinical outcomes. Experimental Design: Automated Quantitative Immunofluorescence Analysis (AQUA) of GSK3β was performed on a tissue microarray with samples from 163 patients treated on RTOG 9704. On the basis of findings in an exploratory cohort, GSK3β was analyzed as a categorical variable using its upper quartile (

AB - Purpose: GSK3β is a protein kinase that can suppress a number of key oncoproteins. We have previously shown in preclinical models of pancreatic ductal adenocarcinoma (PDAC) that inhibition of GSK3β causes stabilization and nuclear translocation of b-catenin, poor differentiation, proliferation, and resistance to radiation. The objective of this study was to determine its utility as a biomarker of clinical outcomes. Experimental Design: Automated Quantitative Immunofluorescence Analysis (AQUA) of GSK3β was performed on a tissue microarray with samples from 163 patients treated on RTOG 9704. On the basis of findings in an exploratory cohort, GSK3β was analyzed as a categorical variable using its upper quartile (

UR - http://www.scopus.com/inward/record.url?scp=84954144917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954144917&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-15-0789

DO - 10.1158/1078-0432.CCR-15-0789

M3 - Article

C2 - 26240274

AN - SCOPUS:84954144917

VL - 21

SP - 5612

EP - 5618

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 24

ER -